
The benefit of bisphosphonates beyond 3 years in preventing fracture is unproven, according to a recent systematic review of the clinical data. The number of people in India with osteoporosis is expected to hit 36 million by 2013, according to a 2012 article in the Journal of Family Medicine and…
Read more »
Bisphosphonates linked to atypical femoral fracture
While reducing the risk of classic fracture, treatment with bisphosphonates may increase the risk of atypical fractures of the femur, with a longer duration of treatment linked to this increasing risk, according to a new study. “We have demonstrated that the association between bisphosphonate treatment and the occurrence of atypical…
Read more »